Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,810 | 862 | 99.0% |
| Education | $119.69 | 3 | 0.5% |
| Consulting Fee | $114.23 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,014 | 85 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,681 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,715 | 77 | $0 (2024) |
| GENZYME CORPORATION | $1,663 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,593 | 77 | $0 (2024) |
| CSL Behring | $1,366 | 61 | $0 (2024) |
| ABBVIE INC. | $1,096 | 40 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,023 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,013 | 49 | $0 (2022) |
| PFIZER INC. | $1,007 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,964 | 143 | AstraZeneca Pharmaceuticals LP ($664.09) |
| 2023 | $3,435 | 139 | AstraZeneca Pharmaceuticals LP ($331.09) |
| 2022 | $3,697 | 140 | ABBVIE INC. ($566.92) |
| 2021 | $2,691 | 113 | AstraZeneca Pharmaceuticals LP ($313.40) |
| 2020 | $1,464 | 72 | OptiNose US, Inc. ($233.52) |
| 2019 | $3,175 | 99 | Regeneron Healthcare Solutions, Inc. ($796.15) |
| 2018 | $2,318 | 82 | Novartis Pharmaceuticals Corporation ($519.92) |
| 2017 | $2,300 | 82 | Teva Pharmaceuticals USA, Inc. ($472.67) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: GENETIC DISEASE | ||||||
| 12/17/2024 | Amgen Inc. | ACTIMMUNE (Biological) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Bone/Inflammation/Rare Disease | ||||||
| 12/16/2024 | Greer Laboratories, Inc. | ORALAIR (Biological) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Allergy Treatment | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $29.97 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/25/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: BIOLOGIC | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Immunology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $116.78 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.99 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.61 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $34.70 | General |
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Immunology | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: BIOLOGIC | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.42 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 199 | 2,513 | $102,702 | $22,126 |
| 2022 | 7 | 125 | 1,970 | $67,172 | $15,048 |
| 2021 | 6 | 118 | 1,385 | $45,496 | $9,815 |
| 2020 | 5 | 89 | 1,722 | $43,906 | $8,186 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 25 | 1,919 | $34,542 | $5,487 | 15.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $13,770 | $3,669 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 50 | $10,100 | $3,204 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,600 | $2,793 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 29 | $8,700 | $2,617 | 30.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 15 | 190 | $9,500 | $2,076 | 21.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 119 | $8,330 | $1,204 | 14.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 16 | 136 | $8,160 | $1,076 | 13.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 22 | 1,609 | $28,962 | $4,826 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $8,220 | $2,330 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $6,400 | $2,077 | 32.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 13 | 170 | $8,500 | $2,033 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $4,350 | $1,514 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 14 | $4,140 | $1,428 | 34.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 16 | 110 | $6,600 | $839.19 | 12.7% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 17 | 1,192 | $21,456 | $3,330 | 15.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 25 | 25 | $6,750 | $2,083 | 30.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 32 | 32 | $6,400 | $1,649 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 15 | $2,250 | $1,031 | 45.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 23 | $2,760 | $951.72 | 34.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 11 | 98 | $5,880 | $770.28 | 13.1% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 22 | 1,567 | $28,206 | $4,509 | 16.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 29 | 29 | $5,800 | $1,446 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 20 | $3,000 | $1,077 | 35.9% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 12 | 93 | $5,420 | $749.81 | 13.8% |
About Alan Redding
Alan Redding is a Allergy & Immunology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134336068.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alan Redding has received a total of $23,044 in payments from pharmaceutical and medical device companies, with $3,964 received in 2024. These payments were reported across 870 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($22,810).
As a Medicare-enrolled provider, Redding has provided services to 531 Medicare beneficiaries, totaling 7,590 services with total Medicare billing of $55,175. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine
- Location Atlanta, GA
- Active Since 05/17/2007
- Last Updated 08/29/2011
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1134336068
Products in Payments
- DUPIXENT (Biological) $3,221
- XOLAIR (Biological) $1,249
- RINVOQ (Biological) $1,055
- NUCALA (Biological) $1,050
- FASENRA (Drug) $988.67
- Xhance (Drug) $851.16
- Haegarda (Biological) $758.47
- TEZSPIRE (Biological) $675.47
- Hizentra (Biological) $593.81
- DUPIXENT DUPILUMAB INJECTION (Biological) $565.99
- OPZELURA (Drug) $501.10
- FASENRA (Biological) $456.50
- TAKHZYRO (Biological) $438.98
- RUCONEST (Biological) $424.64
- EUCRISA (Drug) $424.00
- TRELEGY ELLIPTA (Drug) $413.59
- ALVESCO (Drug) $402.45
- CINQAIR (Drug) $388.48
- Xembify (Biological) $388.30
- ORLADEYO (Drug) $360.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Atlanta
Dr. Deborah Birx, M.d, M.D
Allergy & Immunology — Payments: $470,074
Paul Rabinowitz, M.d, M.D
Allergy & Immunology — Payments: $88,679
Gerald Lee, Md, MD
Allergy & Immunology — Payments: $49,802
Merin Kalangara, Md, MD
Allergy & Immunology — Payments: $33,159
Dr. David Redding, Md, MD
Allergy & Immunology — Payments: $22,643
Mark Livezey, M.d., Ph.d, M.D., PH.D
Allergy & Immunology — Payments: $12,961